New member to WSO here. What is Guggenheim’s current rep in the M&A space? Haven’t typically heard much about them advising on big time deals, but I’m new to the industry.
| +178 | Americas M&A League Table Q2 Updated | 73 | 10h |
| +132 | New Article: Dramatic Slide as UBS #22 (US) & New Leadership Desperately Needed | 26 | 18m |
| +108 | Restructuring: Anti-climactic Experience | 26 | 8h |
| +74 | A COMPLETE GUIDE TO SUMMER INTERNSHIP RECRUITING | 12 | 1d |
| +74 | IB Net Worth / Savings Check | 29 | 2h |
| +51 | Boutique firm wants access to my LinkedIn? | 40 | 1d |
| +39 | Investment Banking is Hard | 17 | 19h |
| +31 | PWP vs BofA | 23 | 2h |
| +25 | Who pays the highest right now? | 14 | 3h |
| +21 | Big 4 Transaction diligence (FDD) vs Valuations and modeling for goal to get in IB | 5 | 4d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Ah, welcome to the jungle, new member! Diving right into the thick of it, are we? Guggenheim's presence in the M&A space is quite the topic of interest. Based on the highest ranked content on WSO, here's the scoop:
Guggenheim has been making waves with some significant deals, showcasing their prowess in the M&A arena. They've been part of multi-billion dollar transactions, which is no small feat. For instance, they played a key role in advising on the Disney acquisition of Fox, a deal valued at a whopping $66 billion. Additionally, they've been involved in other substantial deals like Sanofi's acquisition of Bioverativ for $11 billion. These are not just numbers; they're hefty endorsements of Guggenheim's capabilities in handling big-time M&A deals.
Moreover, their reputation seems to be on an upward trajectory. The firm has been part of discussions around whether it's ascending to the ranks of elite boutiques, especially given their involvement in such high-profile transactions. This suggests an improving stance in the M&A space, potentially enhancing their exit opportunities and overall prestige in the industry.
However, it's also worth noting that opinions on Guggenheim can vary. While they've been part of some headline-grabbing deals, there's a mix of perceptions about their deal flow and culture. Some discussions highlight their strengths in specific sectors, like securitized products banking, where they're considered a top player for the more complex, esoteric deals.
In summary, Guggenheim is definitely a player in the M&A space, with involvement in significant deals that have caught the industry's eye. Like any firm, they have their areas of strength and sectors where they shine. As you're new to the industry, keeping an eye on such firms and their deal activities can offer valuable insights into the dynamic world of investment banking. Welcome aboard, and may your journey through the financial jungle be both enlightening and thrilling!
Sources: Millstein acquired by Guggenheim. Thoughts?, Honest thoughts on Guggenheim, https://www.wallstreetoasis.com/forum/investment-banking/db-nyc-vs-guggenheim-nyc-vs-rbc-nyc-ma-vs-tph-pwp-houston-for-2019-sa-ft?customgpt=1, Guggenheim Ascending?, Guggenheim NYC: updated reputation, culture, exits
Last year they finished 13th overall in league tables, ahead of PJT, PWP and Moelis.
They had third biggest M&A deal of 2023, 43 billion Pfizer deal.
Good firm extremely strong HC practice. It’s not really fair to compare it with PWP/PJT since Guggenheim is significantly larger than the two firms— but it has made significant strides to building out both M&A and rx franchises and it’s starting to show. The most comparable firms are Evercore and Jefferies from a business model perspective(since these 3 firms have sales and trading, capital markets and ER but still are considered independent model, not from a prestige perspective.)
in terms of analyst experience I’ve heard it’s really group dependent, and exits are similar good analyst can recruit essentially anywhere without much difficulty.
Thanks. Appreciate ur response. Looking to break into IB from a senior associate/vp role in real estate investments. I knew of Guggenheim’s reputation in Asset Management & Securities trading but not much on the M&A side. How’s Jeffries’ rep in M&A? I hear many good things about Evercore.
If I got a dollar for every time someone spelt Jefferies as Jeffries, I wouldn't have to work in IB anymore.
To answer your question, Jefferies was top 10 for IB globally last year, and 6th for M&A year-to-date (granted it is early). Has an M&A group but most of the modeling is done in-house for the top groups (healthcare, energy, fig, tech). They do all kinds of deals (sub-$200 mil to >$2 bn) and will not shy away from the complex deals that other banks didn't want. They also added a shit-ton of MDs last year so I don't think any of the analysts are sitting around twiddling their thumbs and have generally avoided mass layoffs compared to other banks. In one of the coverage groups myself and it has been extremely busy but a great experience from a reps point-of-view.
you would consider fig a top group at jeff now? considering a lateral into there and most of the info on here is from early CS integration days
Coming from outside the IB industry, you'd be fortunate to land a job at any of these firms. I wouldn't be too picky as, without industry experience, you've already got 2 strikes against you with respect to landing an IB role without getting an MBA.
Commodi dolorem temporibus et qui mollitia. Sapiente beatae fugiat iste. Fugiat deserunt reiciendis repudiandae recusandae error enim vitae. Ab est amet excepturi quam sit.
Excepturi nam eaque est accusantium. Vel dolores quae non dolor et pariatur.
Et aut veniam et et tempora debitis placeat. Dolor voluptatibus ipsum cumque neque eum hic a suscipit. Autem molestiae velit sit consequatur cupiditate. Cupiditate velit quia quos.
Nihil nihil eum labore laboriosam deleniti quisquam ut. Quo laborum reprehenderit quos dolor sequi recusandae rerum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...